The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46.
CSX Corporation
CSX · a US exchange · USD · Market cap $94.2B · 22,200 employees
CSX Corporation, together with its subsidiaries, provides rail-based freight transportation services in the United States and Canada.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 08:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price52.05 USD at the 13 Nov 2026 close
- Our value readFair vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.24)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $35.15 to $58.59, base estimate $50.72 (screen dated 2026-11-13).
- Trend Markup
- Insiders insiders sold, $999,180, latest filing 2026-10-26
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.24, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
CSX Corporation holds its Markup at $52.05. Consolidating, no directional conviction, held for 15 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 15 days |
| Price at the screen | $52.05 |
| Valuation | 26.60 trailing · 21.80 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.11 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 44.30% | Below 33% | Interest-bearing debt is 44.3% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 6.03% | Below 33% | Cash held in interest-bearing accounts and securities is 6.0% of assets, under the one-third limit. | Pass |
| Receivables | 3.61% | Below 49% | Money owed to the company is 3.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.32% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
CSX's business is in a permissible area, but its interest-bearing debt is about 44% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CSX's ethical verdict changes
Today CSX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades above our $50.72 fair value estimate, strong competitive moat, 12.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 2.6% above the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Our model and the Street both land near the screened price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere our models see it going: fair-value estimate $50.72, with a range of $35.15 to $58.59, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFreight Rails Face Debt Screen Test
Goods still move across America on steel tracks the way they have for generations, yet CSX shows why not every steady operator earns a place in a disciplined book. The business prints a 22 percent profit margin and 24 percent ROE with a strong moat, but revenue barely rises 2 percent and the shares trade above our fair value at a forward multiple of 22.8 times. That combination fails to clear the bar.
We pass because the ethical screen flags the debt ratio first. A high leverage load sits at odds with the modest growth outlook, and paying up for the shares leaves no margin of safety when the next cycle turns. Strong returns on equity can mask rising interest costs once volumes soften.
Twenty-three analysts still rate the name a buy with a median target above the current price, yet consensus rarely prices in balance-sheet fragility or ethical screens. The market may keep cheering rail stability, but the debt overhang and thin growth leave the risk profile unattractive. Analysis, not advice.
| Forward P/E | 21.8xpriced for continued growth |
| Trailing P/E | 26.6xa premium valuation |
| EPS, trailing | 1.92 |
| EPS, forward | 2.34 |
| Revenue growth | +12.0%steady growth |
| Profit margin | 24.0%healthy profit margins |
| Return on equity | 26.4%an exceptional return on shareholder capital |
| FCF yield | 2.57% |
| Dividend yield | 1.23% |
| Debt to equity | 1.35a meaningful debt load worth watching |
| Current ratio | 0.84below 1: short-term bills exceed liquid assets |
| Beta | 1.11moves a little more than the market |
| Short interest, float | 0.02% |
| 52-week range | 33.63 - 53.60 |
| Moat | STRONG |
| Market cap | $94.2B |
| Employees | 22,200 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCSX trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it buy, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Apple Leads Five Stocks Standing Tall Near Buy Points Despite Nvidia, Other Headwinds Yahoo Finance · 2d ago
- Could You Have Seen The Run In CSX Stock Coming? Yahoo Finance · 4d ago
- Amid Stubborn Diesel Prices, These Railroad Stocks Eye Breakouts Yahoo Finance · 4d ago
- CSX Targets Higher Prices and More Freight in 2027 as Trucking Capacity Tightens Yahoo Finance · 5d ago
- Zacks Industry Outlook Highlights Union Pacific, CSX and Norfolk Southern Yahoo Finance · 6d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Zillmer John J | Dir | S - Sale | 19,500 | $999,180 |
| 2026-03-13 | WHISLER J STEVEN | Director | 954 | $37,492 | |
| 2026-03-06 | ANGEL STEPHEN F | Chief Executive Officer | 25,000 | $1,006,750 | |
| 2026-03-02 | ZILLMER JOHN J | Director | 5,850 | · | |
| 2026-02-26 | KENNEY MARYCLARE T | Officer | 9,379 | · | |
| 2026-02-26 | FORTUNE STEPHEN | Chief Technology Officer | 10,903 | · | |
| 2026-02-26 | CORY MICHAEL A | Chief Operating Officer | 15,241 | · | |
| 2026-02-26 | BURNS MICHAEL S. | Officer | 8,207 | · | |
| 2026-02-26 | BEGEMAN ANN | Director | 4,455 | · | |
| 2026-02-26 | BOONE KEVIN S | Chief Financial Officer | 15,241 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-31 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-31 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-31 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-27 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-27 | Kevin Hern | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $44.60 | +4.6% | $0.14 | $1,049 | +4.9% |
| 2 months | $42.11 | +10.8% | $0.14 | $1,111 | +11.1% |
| 3 months | $39.10 | +19.3% | $0.14 | $1,196 | +19.6% |
| 6 months | $36.91 | +26.4% | $0.28 | $1,271 | +27.1% |
| 1 year | $32.16 | +45.1% | $0.54 | $1,467 | +46.7% |
| 2 years | $31.99 | +45.8% | $1.04 | $1,491 | +49.1% |
| 3 years | $30.95 | +50.7% | $1.50 | $1,555 | +55.5% |
| 5 years | $30.29 | +54.0% | $2.31 | $1,616 | +61.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CSX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.